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Introduction 
Acne is a multifactoral condition that affects 80% of 
people during their second to fourth decades, moreover, 
5% of old people can still experience acne.1 Comedone 
formation and hyperkeratinization remain to be the 
principal culprits in acne illicitation.2 Depressed atrophic 
scars develop due to collagen breakdown following skin 
conditions such as cystic acne and varicella. Trying to hide 
these scars with cosmetics frequently exacerbate their 
appearance by amplifying the textural variety of the skin. 
A number of treatments to improve the appearance of 
atrophic scars were employed in literature with different 
degrees of satisfaction.3
Safety and efficacy of fractional photothermolysis had 
been established since its introduction in 2003 in a 
number of skin conditions including but not only acne, 
scars, pigmentations and wrinkles.4
Fractional technology thermolysis was introduced to 
decrease the side effects and downtime of the ablative 
laser technologies, and at the same time improve on 
the comparatively less effective non-ablative lasers. The 
energy columns introduced to the skin creates columns 
of injury called microthermal zones (MTZs). Healthy 
untreated skin fractions provide a source of rapid healing 
and repair to the coagulated zones removing the necrotic 
debris.5
The distinctive recovery mechanism following fractional 
photothermolysis ensures an early patient recovery 
with less adverse events. Multiple treatments are usually 
required since the coverage area of skin ranges from 5% 
to 40%.6
The non-ablative erbium doped fractional lasers are used 
in many skin conditions owing to its tendency to preserve 
the epidermal functions and reduce the side effects, 
resulting in faster recovery.1–4 Nevertheless, more than 
one session is required to provide a satisfactory outcome.7
Studies on the safety and efficacy of this technology 
among Egyptians are limited. Our study design aimed at 
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Abstract
Introduction: Non-ablative fractional erbium-doped glass 1540 nm and fractional ablative 10600 
nm carbon dioxide lasers are regarded as effective modalities for treating acne atrophic scars. 
In this study, we aimed to compare the effectiveness of fractional CO2 laser and fractional non-
ablative 1540 nm erbium doped glass laser in treating post acne atrophic scars in Egyptian patients. 
Methods: Fifty-eight patients complaining of moderate and severe acne atrophic scars were 
randomly divided into 2 groups of 29 patients each. Both groups were subjected to 4 treatment 
sessions with 3 weeks interval and were followed up for 3 months. In group A, enrolled patients 
received CO2 laser, while in group B, patients were treated with 1540 nm erbium glass fractional 
laser. 
Results: Clinical assessment revealed that the mean grades of progress and improvement were 
higher with fractional 10600 nm CO2 laser but with non-significant difference between both 
treatments (P = 0.1). The overall patients’ satisfaction with both lasers were not significantly different 
(P = 0.44). 
Conclusion: Both fractional ablative CO2 and fractional non-ablative erbium glass lasers are 
good modalities for treating acne scars with a high efficacy and safety profile and good patient 
satisfaction. The fractional ablative laser showed higher efficacy while non-ablative laser offered 
less pain and shorter downtime.
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comparing the effectiveness of ablative fractional CO2 
and non-ablative 1540 nm erbium doped glass fractional 
technologies in improving and treating atrophic scars in 
Egyptian skin tone. 
Methods
Fifty-eight patients (39 females, 19 males, of skin types II-
IV, aged 18-45) who had to fulfill the criteria of presenting 
with moderate to severe atrophic facial acne scars were 
recruited as of June 2011 to October 2013. Scar grading 
system was used to determine the degree of post acne scars. 
Approval of the ethical committee of Al-Azhar University 
was first obtained. All recruited participants were advised 
to sign a consent form before they were enrolled into the 
study and before starting any laser sessions. Exclusion 
criteria included those less than 18 years of age, patients 
with active viral or bacterial infections, pregnant females 
and anyone with a scar history. Randomization divided 
the patients into 2 groups of 29 patients each. In group 
A, enrolled participants received sessions with fractional 
10 600 nm carbon dioxide laser while in group B, patients 
were treated with 1540 nm Erbium glass fractional laser. 
Treatment
Treatment in one group of the enrolled patients was 
carried out with the ablative fractional CO2 laser 
(SmartXide DOT, Deka, Firenze, Italy), while the other 
half of patients received treatment with the non-ablative 
fractional erbium-doped glass 1540 nm laser (Icon, 
Cynosure, USA). Gentle face cleansing was followed by 
application of topical EMLA cream (AstraZeneca AB, 
Sodertalje, Sweden) for 60 minutes before starting the 
laser session. Those with history of herpes infection 
received prophylactic antiviral medication for 3 days 
prior to the laser procedure.
The 2 groups received 4 treatment sessions with a 3 weeks 
free interval between every session. The energy settings 
of the fractional 10 600 nm CO2 laser ranged from 10-15 
W, with 500-1000 µs dwell time, stack 2 and spacing of 
700 µm. The erbium group treatment settings consisted 
of 4 passes with pulse energy of 50-60 mJ⁄cm2 with XD 
Microlens and 15 ms pulse duration. After treatment, 
patients applied a moisturizer and sunscreen (SPF 50+). 
Patients were remotely followed up through phone call on 
the same and next day after treatment to document any 
side effect or adverse event. 
Evaluation 
Two blinded dermatologists determined the patients 
improvement using a 4-grade evaluation scale in which 
grade 1 would show less than 25% improvement; grade 2 
showing 26% to 50% improvement; with grade 3 showing 
51% to 75% improvement; while grade 4, with more than 
75% improvement denoted near to full recovery. The 2 
dermatologists did the assessment using pretreatment 
photographs and post treatment photographs 
Table 1. Clinical Improvement Based on the Quartile Grading Scale
Improvement 10 600 nm (n = 29) 1540 nm (n = 29)
<25% 3 (10.3%) 5 (17.2%)
25%–50% 8 (27.5%) 11 (37.9%)
51%–75% 12 (41.3%) 11 (37.9%)
>75% 6 (20.6%) 2 (6.8%)
χ = 3.172, P = 0.38
Subjective assessment was determined using a 4-grade 
satisfaction scale, patients were classified into very 
satisfied, only satisfied, slightly satisfied or completely 
unsatisfied. Moreover side effects were followed and 
recorded for up to 3 months after the last laser session. 
Pain that accompanied the laser sessions was evaluated 
using a 10-point score with 0 denoting “absent pain” and 
10 denoting “severe pain.” 
Statistical Analysis
Statistical evaluation for this study was completed using 
SPSS for Windows software (SPSS Inc., Chicago, IL, USA, 
version 20). P < 0.05 was considered by investigators to be 
statistically significant. 
Results
All patients recruited successfully completed the full 
length of the study of 4 laser treatments and were followed 
up afterwards for 3 more months. Three months after the 
last laser procedure with fractional 10 600 nm CO2 laser 
(group A), 6 of 29 patients showed excellent improvement 
(>75%), 12 of the recruited patients demonstrated marked 
improvement (51%-75%), 8 of the patients demonstrated 
moderate improvement (25%-50%), and 3 of the patients 
showed poor improvement (<25%). On the other hand, for 
group B patients with fractional 1540 nm erbium doped 
glass, 2 of 29 patients showed excellent improvement 
(>75%), 11 demonstrated marked improvement (51%–
75%), 11 showed moderate improvement (25%-50%), 
while 5 patients showed poor improvement (<25%). 
(Table 1; Figures 1 and  2).
After clinically assessing the patients following the 
sessions and during the follow-ups, the mean grades of 
improvements were 2.7 ± 0.9 for group A and 2.3 ± 0.8 
for group B. Although CO2 laser achieved higher clinical 
improvement than erbium glass, clinical improvement 
scores between both laser treatments did not show any 
significance statistically (P = 0.1). The overall patients’ 
satisfaction was 48.1 % for ablative fractional CO2 
group and 41 % for non-ablative laser group with a non-
significant difference (P = 0.44) (Table 2). For clinical 
improvement, the investigator and subject assessments 
at 3 months did not differ significantly between the 
investigator and subjects.
In group A, post laser treatment downtime mean 
(crusting, scaling and erythema) was 5.2 ± 1.05 days. In 
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group B, post-laser session downtime (erythema) mean 
was 2.1 ± 0.81 days. This difference in the downtime 
duration following laser sessions was statistically 
significant (P < 0.001). 
The mean VAS pain score associated with the procedures 
was 5.93 ± 1.39 for group A and 4.41 ± 1.30 for group 
B (P < 0.001). In group A, 3 patients showed post-
inflammatory hyperpigmentation, 2 patients showed 
acneiform eruption and one patient showed herpes 
simplex outbreaks after laser treatment, while in group 
B, only acneiform eruption was noticed with one patient 
after the laser sessions.
Discussion
Fractional ablative resurfacing (AFR) technology using 
10 600 nm carbon dioxide laser relies on the formation 
of ablated, vaporized columns of tissue surrounded by 
annular zones of coagulation and dermal remodelling.8 
Table 2. Overall Patients’ Satisfaction
Improvement 10 600 nm (n = 29) 1540 nm (n = 29)
Not satisfied 7 (24.1%) 7 (24.1%)
Slightly satisfied 8 (27.5%) 13 (44.8%)
Satisfied 11 (37.9%) 8 (27.5%)
Very satisfied 3 (10.3%) 1 (3.4%)
χ = 2.664, P = 0.44.
Figure 1. A 27-Year-Old Female Patient With Post-acne Scar, Before and 
After 3 Sessions of Fractional CO2 Laser.
Figure 2. A 24-Year-Old Male Patient With Post-acne Scar, Before and After 
3 Sessions of Fractional Erbium Glass 1540 nm Laser.
On the other hand the erbium-doped glass laser is a 
fractional laser that utilizes a non-ablative technology 
inducing columns of MTZs with much less downtime and 
with reported high efficacy in treating acne scars.9,10
In high energies, the 1540 nm, non-ablative, erbium 
glass laser can reach depths exceeding 1000 μm, while 
the mean penetration depth stands at 679 μm with 
moderate energy modes.11 At this wavelength, the main 
chromophores absorbing laser energy are the sebaceous 
glands, water and adjacent dermal tissues while melanin 
remains to be spared. Minimal side effects, downtime 
and superior results were all demonstrated in multiple 
previous studies.12,13
This study was designed to assess and compare the 
effectiveness of fractional CO2 laser and fractional 
non-ablative 1540 nm erbium doped glass laser in the 
treatment of atrophic acne scars in Egyptian patients. We 
aimed to investigate the safety of the treatments as well as 
patients satisfaction following treatment as well.
Ninety days after the final laser treatment session, a 
significant improvement was seen in both groups. 
Objective clinical assessment by quartile grading scale 
revealed a significant improvement in both. Sixty-two 
percent of patients treated with fractional CO2 laser 
attained more than 50% improvement while 44.8% of 
the patients treated with fractional erbium doped glass 
attained more than 50% improvement. At the 3 months 
post laser follow up, patients treated with CO2 laser 
showed a higher improvement that was not statistically 
significant (P = 0.38). Treatment with fractional CO2 
laser was associated with a significant higher downtime 
than with fractional non-ablative 1540 nm erbium glass, 
including post-treatment crust formation, scaling and 
erythema. Pain assessment scores were relatively high 
using the ablative carbon dioxide in comparison to the 
non-ablative erbium glass.
In consistence with our study, Hedelund et al14 showed 
a statistically significant improvement in atrophic post 
acne scar in comparison with placebo after 3 monthly 
laser sessions with fractional CO2 device. The study 
was conducted on 13 patients and the patients were also 
quoted as being ‘satisfied’ following the laser session 
treatments.
Three months after the last laser session in a study 
conducted by Cho et al,15 the clinical assessment of the 
participants in the study showed mean improvements 
in all groups of both lasers, treatments did not show 
statistically significant differences between fractional 
non-ablative 1550-nm erbium glass laser and fractional 
ablative CO2 laser (P = 0.249). 
In consistence with our study, Cho et al7 demonstrated 
that the mean improvements were higher with fractional 
10 600 nm CO2 laser than fractional non-ablative 1550-
nm erbium-glass but with a non-significant difference 
between both treatments (P = 0.158). The overall patients’ 
satisfaction levels of fractional 1550-nm glass and 
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fractional 10 600 nm CO2 laser sessions did not reveal any 
difference of significance (P = 0.105). 
Conclusion 
According to both the subjective and investigators 
assessment, it is possible to consider that both fractional 
ablative CO2 and fractional non-ablative erbium glass 
lasers represent a useful tool to treat acne scars. Moreover 
both types of laser represent a modality with a safe 
profile and that can achieve good patient satisfaction. 
Additionally, the fractional ablative laser might offer a 
higher efficacy for acne scars, while the fractional non-
ablative might offer a less painful treatment with a shorter 
downtime.
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